| Accelerating rare disease drug development: lessons learned from muscular dystrophy patient advocacy groups RA Huml, J Dawson, M Bailey, N Nakas, J Williams, M Kolochavina, ... Therapeutic Innovation & Regulatory Science 55, 370-377, 2021 | 13 | 2021 |
| Use of big data to aid patient recruitment for clinical trials involving biosimilars and rare diseases RA Huml, J Dawson, K Lipworth, L Rojas, EJ Warren, C Manaktala, ... Therapeutic Innovation & Regulatory Science 54, 870-877, 2020 | 6 | 2020 |
| Patient benefits from innovative designs in rare diseases Z Antonijevic, RA Beckman, JR Huml, Y Liu, C Mayer, G McMillan, R Tang Rare Disease Drug Development: Clinical, Scientific, Patient, and Caregiver …, 2021 | 1 | 2021 |
| Sparse, Geometric Autoencoder Models of V1 J Huml, A Tasissa, D Ba Symmetry and Geometry in Neural Representations @ NeurIPS, 2023 | | 2023 |
| Clustering Inductive Biases with Unrolled Networks J Huml, A Tasissa, D Ba Computational and Systems Neuroscience (COSYNE), 2023 | | 2023 |
| Local Geometry Constraints in V1 with Deep Recurrent Autoencoders J Huml, A Tasissa, D Ba SVRHM 2022 Workshop@ NeurIPS, 2022 | | 2022 |
Demba BaHarvardVerified email at seas.harvard.edu
